Valence8 US »

Vistagen Therapeutics Ord shares owned by Valence8 US

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $104k 34k 3.01

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding Vistagen Therapeutics Ord

TCG Crossover Management
BVF
Stempoint Capital
Vanguard Group
Commodore Capital
Nantahala Capital Management
Sphera Funds Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Renaissance Technologies
Goldman Sachs Group
Squarepoint Ops

View all funds holding Vistagen Therapeutics Ord